Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa

Journal of Endocrinology

Volumn 188, Issue 2, 2006, Pages 311-319

  Lu, Yen Shen ^a,c   Yeh, Pei Yen ^a   Chuang, Shuang En ^b   Gao, Ming ^a,c   Kuo, Min Liang ^c   Cheng, Ann Lii ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIFEPRISTONE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL SELECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURAL HOMOLOGY; UTERINE CERVIX CARCINOMA;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CISPLATIN; DEXAMETHASONE; GENE EXPRESSION REGULATION; HORMONE ANTAGONISTS; HUMANS; IMMEDIATE-EARLY PROTEINS; MIFEPRISTONE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, GLUCOCORTICOID;

EID: 33244480810     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06453     Document Type: Article

References (36)

1. Andrews NC & Faller DV 1991 A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 19 2499.
2. Auphan N, Di Donato JA, Rosette C, Helmberg A & Karin M 1995 Immunosuppression by glucocorticoids: inhibition of NF-kB activity through induction of I kB synthesis. Science 270 286-290.
3. Beato M, Herrich P & Schutze G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83 851-857.
4. Beck CA, Estes PA, Bona BJ, Muro-Cacho CA, Nordeen SK & Edwards DP 1993 The steroid antagonist RU486 exerts different effects on the glucocorticoids and progesterone receptors. Endocrinology 133 728-740.
5. Beg AA & Baltimore D 1996 An essential role for NF-κB in preventing TNF-alpha-induced cell death. Science 274 782-784.
6. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 248-254.
7. Carmichael J, DeGraff WG, Gazdar AF, Minna JD & Mitchell JB 1987 Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research 47 936-942.
8. Cato AC & Wade E 1996 Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18 317-378.
9. Chang TC, Hung MW, Jiang SY, Chu JT, Chu LL & Tsai LC 1997 Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression. FEBS Letters 415 11-15.
10. Chang TC, Tsai LC, Hung MW, Chu LL, Chu JT & Chen YC 1997 Effects of transcription and translation inhibitors on a human gastric carcinoma cell line. Potential role of Bcl-X(S) in apoptosis triggered by these inhibitors. Biochemical Pharmacology 53 969-977.
11. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH & Ballard DW 1997 Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. PNAS 94 10057-10062.
12. Gassler N, Zhang C, Wenger T, Schnabel PA, Dienemann H, Debatin KM, Mattern J & Herr I 2005 Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. British Journal of Cancer 28 1084-1088.
13. Harmon JM & Thompson EB 1981 Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-CT. Molecular Cell Biolology 1 512-521.
14. Haskell CM 1995 Antineoplastic agents. In Cancer Treatment, edn 4, pp 105-106. Eds Haskell CM & Break JS. Philadelphia: WB Saunders.
15. Legrand-Poels S, Bours V, Piret B, Pflaum M, Epe B, Rentier B & Piette J 1995 Transcription factor NF-κB is activated by photosensitization generating oxidative DNA damages. Journal of Biological Chemistry 270 6925-6934.
16. Lindemeyer RG, Robertson NM & Litwack G 1990 Glucocorticoid receptor monoclonal antibodies define the biological action of RU 38486 in intact B16 melanoma cells. Cancer Research 50 7985-7991.
17. Lippman ME, Yarbro GK & Leventhal BG 1978 Clinical implications of glucocorticoid receptors in human leukemia. Cancer Research 38 4251-4256.
18. Lu YS, Lien HC, Yeh PY, Yeh KH, Kuo ML, Kuo SH & Cheng AL 2005 Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors. World Journal of Gastroenterology 11 6373-6380.
19. McEwan IJ, Wright AP & Gustafsson JA 1997 Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays 19 153-160.
20. Naumann U, Durka S & Weller M 1998 Dexamethasone-mediated protection from drug cytotoxicity: association with p21 WAF1/CIP1 protein accumulation? Oncogene 17 1567-1575.
21. Piret B & Piette J 1996 Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells. Nucleic Acids Research 24 4242-4248.
22. Quinto I, Ruocco MR, Baldassarre F, Mallardo M, Dragonetti E & Scala G 1993 The human immunodeficiency virus type 1 long terminal repeat is activated by monofunctional and bifunctional DNA alkylating agents in human lymphocytes. Journal of Biological Chemistry 268 26719-26724.
23. Ray A & Prefontaine KE 1994 Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. PNAS 91 752-756.
24. Scheidereit C, Geisse S, Westphal HM & Beato M 1983 The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature 304 749-752.
25. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA & Baldwin AS Jr. 1995a Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Molecular Cell Biology 15 943-953.
26. Scheinman RI, Cogswell PC, Lofquist AK & Baldwin AS Jr. 1995b Role of transcriptional activation of IkB α in mediation of immunosuppression by glucocorticoids. Science 270 283-286.
27. Segnitz B & Gehring U 1990 Mechanism of action of a steroidal antiglucocorticoid in lymphoid cells. Journal of Biological Chemistry 265 2789-2796.
28. Shishodia S & Aggarwal BB 2004 Nuclear factor-κB: a friend or a foe in cancer? Biochemical Pharmacology 68 1071-1080.
29. Staal FJ, Roederer M, Herzenberg LA & Herzenberg LA 1990 Intracellular thiols regulate activation of nuclear factor-κB and transcription of human immunodeficiency virus. PNAS 87 9943-9947.
30. The Italian Group of Anticancer Research 1995 Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. New England Journal of Medicine 332 1-5.
31. The Italian Group of Anticancer Research 2000 Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. New England Journal of Medicine 342 1554-1559
32. van Antwerp DJ, Martin SJ, Kafri T, Green DR & Verma IM 1996 Suppression of TNF-alpha-induced apoptosis by NF-κB. Science 274 787-789.
33. Van der Burg B, Okret S, Liden J, Wissink S, Van der Saag PT & Gustafsson JA 1997 Nuclear factor-κB repression in anti-inflammation and immunosuppression by glucocorticoids. Trends in Endocrinology and Metabolism 8 152-157.
34. Wang CY, Mayo MW & Baldwin AS 1996 TNF-alpha and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274 784-787.
35. Wissink S, van Heerde EC, van der Burg B & van der Saag PT 1998 A dual mechanism mediates regression of NF-κB activity by glucocorticoids. Molecular Endocrinology 12 355-363.
36. Wu W, Pew T, Zou M, Pang D & Conzen SD 2005 Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. Journal of Biological Chemistry 11 4117-4124.